Table 5 APR-DRG score, comorbidities, and clinical conditions comparing patients living in neighborhoods of income at the lowest and highest quartiles who underwent isolated SAVR.
Low SES (n = 10,029), n (%) | High SES (n = 10,811), n (%) | p-value | |
|---|---|---|---|
APR-DRG risk of mortality subclass | |||
Class 1 | 1500 (14.96%) | 1926 (17.82%) | < 0.01 |
Class 2 | 2980 (29.71%) | 3571 (33.03%) | < 0.01 |
Class 3 | 3161 (31.52%) | 3366 (31.13%) | 0.56 |
Class 4 | 2388 (23.81%) | 1948 (18.02%) | < 0.01 |
Comorbidities | |||
Acquired immune deficiency syndrome | 66 (0.66%) | 27 (0.25%) | < 0.01 |
Alcohol abuse | 358 (3.57%) | 292 (2.7%) | < 0.01 |
Autoimmune conditions | 311 (3.1%) | 338 (3.13%) | 0.94 |
Lymphoma | 37 (0.37%) | 61 (0.56%) | 0.04 |
Leukemia | 23 (0.23%) | 31 (0.29%) | 0.50 |
Metastatic cancer | 25 (0.25%) | 35 (0.32%) | 0.37 |
Solid tumor without metastasis, in situ | 2 (0.02%) | 2 (0.02%) | 1.00 |
Solid tumor without metastasis, malignant | 100 (1%) | 128 (1.18%) | 0.21 |
Cerebrovascular disease | 199 (1.98%) | 154 (1.42%) | < 0.01 |
Heart Failure | 3 (0.03%) | 6 (0.06%) | 0.51 |
Dementia | 103 (1.03%) | 76 (0.7%) | 0.01 |
Depression | 986 (9.83%) | 895 (8.28%) | < 0.01 |
Diabetes without chronic complications | 1290 (12.86%) | 983 (9.09%) | < 0.01 |
Diabetes with chronic complications | 1591 (15.86%) | 1343 (12.42%) | < 0.01 |
Drug abuse | 476 (4.75%) | 173 (1.6%) | < 0.01 |
Complicated hypertension | 3645 (36.34%) | 3214 (29.73%) | < 0.01 |
Uncomplicated hypertension | 4100 (40.88%) | 4770 (44.12%) | < 0.01 |
Moderate to advanced liver disease | 10 (0.1%) | 12 (0.11%) | 0.83 |
Chronic pulmonary disease | 2348 (23.41%) | 1698 (15.71%) | < 0.01 |
Obesity | 2670 (26.62%) | 2369 (21.91%) | < 0.01 |
Paralysis | 147 (1.47%) | 93 (0.86%) | < 0.01 |
Peripheral vascular disease | 2468 (24.61%) | 3195 (29.55%) | < 0.01 |
Advanced renal failure | 226 (2.25%) | 117 (1.08%) | < 0.01 |
Hypothyroidism | 1186 (11.83%) | 1375 (12.72%) | 0.05 |
Other thyroid disorders | 109 (1.09%) | 181 (1.67%) | < 0.01 |
Coronary artery disease | 4016 (40.04%) | 10,161 (66.8%) | < 0.01 |
Left ventricle dysfunction | 45 (0.45%) | 38 (0.35%) | 0.27 |
Pulmonary hypertension | 1458 (14.54%) | 1194 (11.04%) | < 0.01 |
Endocarditis | 1015 (10.12%) | 808 (7.47%) | < 0.01 |
Atrial fibrillation | 4108 (40.96%) | 4869 (45.04%) | < 0.01 |
Atrial flutter | 705 (7.03%) | 891 (8.24%) | < 0.01 |
Ventricular fibrillation | 234 (2.33%) | 195 (1.8%) | 0.01 |
Ventricular flutter | 0 (0%) | 2 (0.02%) | 0.50 |
Sick sinus syndrome | 227 (2.26%) | 251 (2.32%) | 0.78 |
First-degree atrioventricular block | 327 (3.26%) | 500 (4.62%) | < 0.01 |
Second-degree atrioventricular block | 97 (0.97%) | 118 (1.09%) | 0.41 |
Complete atrioventricular block | 749 (7.47%) | 1449 (9.53%) | < 0.01 |
Carotid artery disease | 8 (0.08%) | 5 (0.05%) | 0.41 |
Hyperlipidemia | 5313 (52.98%) | 6418 (59.37%) | < 0.01 |
Anemia | 506 (5.05%) | 286 (2.65%) | < 0.01 |
Thrombocytopenia | 2881 (28.73%) | 3604 (33.34%) | < 0.01 |
Sleep apnea | 1512 (15.08%) | 1866 (17.26%) | < 0.01 |
Tobacco use | 4439 (44.26%) | 3895 (36.03%) | < 0.01 |
Previous MI | 569 (5.67%) | 423 (3.91%) | < 0.01 |
Previous CVA | 570 (5.68%) | 640 (5.92%) | 0.48 |
Previous CABG | 377 (3.76%) | 315 (2.91%) | < 0.01 |
Previous PCI | 643 (6.41%) | 642 (5.94%) | 0.16 |
Previous valve replacement | 350 (3.49%) | 366 (3.39%) | 0.70 |
